What MTHFR Variants Do To Folate Metabolism

MTHFR variants appear on nearly every consumer genetic report and attract disproportionate attention. The biochemistry is well characterised, which makes the gap between mechanism and claims easy to see.

The enzyme performs one conversion

Folate exists in several chemical forms serving different roles. The enzyme converts one form into the specific form used to donate a carbon group during a particular reaction.

That reaction converts homocysteine into methionine, which is then used to make the cell's principal donor of methyl groups for numerous other reactions.

The enzyme therefore sits at a junction between folate handling and methyl group supply, which is why its effects are described across several processes.

The common variant reduces activity partially

The most discussed variant produces an enzyme less stable at higher temperatures, resulting in reduced activity rather than absence of function.

People carrying two copies have substantially reduced activity; carrying one copy produces a smaller reduction. The variant is common enough that carriers are numerous in most populations.

Reduced activity is not the same as a blocked pathway. Other routes contribute to the same conversion, and remaining enzyme activity continues to function.

Folate intake modifies the effect

The measurable consequence of the variant is a modest rise in homocysteine, and that rise is most apparent when folate intake is low.

Where intake is adequate, the difference between genotypes narrows considerably. This is a genuine gene-nutrient interaction and the basis of the interest.

It also means the variant's relevance depends on dietary context rather than being fixed, which complicates any universal recommendation attached to it.

Downstream claims outrun the evidence

The variant has been linked to a wide range of conditions, largely through studies associating raised homocysteine with those outcomes.

Trials lowering homocysteine have generally not produced the outcome improvements those associations predicted, which weakens the causal interpretation.

Attributing a broad set of symptoms to the variant therefore rests on a chain where a middle link has been tested and did not hold.

Testing has limited clinical use

Professional genetics bodies have advised against routine testing for this variant in most circumstances, on the grounds that results rarely change management.

Where homocysteine is genuinely elevated, measuring it directly is more informative than inferring it from genotype, since many factors influence the level.

Decisions about folate intake, particularly around pregnancy or with any diagnosed condition, belong with a clinician rather than being derived from a consumer report.